1,123 results on '"Sachinidis, Agapios"'
Search Results
2. Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
3. Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
4. Live Cell Imaging funktionaler Parameter von Kardiomyozyten
5. Risk assessment of parabens in a transcriptomics-based in vitro test
6. Microgravity-induced stress mechanisms in human stem cell-derived cardiomyocytes
7. High-efficient serum-free differentiation of endothelial cells from human iPS cells
8. Epigenetic mechanisms of Strip2 in differentiation of pluripotent stem cells
9. IL12 integrated into the CAR exodomain converts CD8+ T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
10. Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice
11. Kcnh2 deletion is associated with rat embryonic development defects via destruction of KCNH2‑integrin β1 complex
12. High-throughput base editing: a promising technology for precision medicine and drug discovery
13. Enhanced hippocampal type II theta activity AND altered theta architecture in mice lacking the Cav3.2 T-type voltage-gated calcium channel
14. Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages
15. Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease
16. Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances
17. Correction to: Toxicogenomics directory of chemically exposed human hepatocytes
18. Road Map for Development of Stem Cell-Based Alternative Test Methods
19. Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice
20. Unmusking of Protein Phosphatase 2 Regulatory Subunit B as a crucial factor in the development and progression of dilated cardiomyopathy
21. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
22. Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes
23. Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
24. Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures
25. Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
26. Supplementary Data from Gene Expression–Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial
27. Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases
28. Exogenous WNT5A and WNT11 proteins rescue CITED2 dysfunction in mouse embryonic stem cells and zebrafish morphants
29. Loss of genomic integrity induced by lysosphingolipid imbalance drives ageing in the heart
30. Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells
31. Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors
32. Signaling molecules, transcription growth factors and other regulators revealed from in-vivo and in-vitro models for the regulation of cardiac development
33. Myeloperoxidase is a Critical Mediator of Anthracycline-induced Cardiomyopathy
34. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
35. Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
36. Impairment of human neural crest cell migration by prolonged exposure to interferon-beta
37. Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests
38. Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay
39. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
40. Human Induced Pluripotent Stem Cells: Role in Patient-Specific Drug Discovery
41. Inhibition of MLKL impairs abdominal aortic aneurysm development by attenuating smooth muscle cell necroptosis
42. High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast Differentiation
43. A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system
44. Aspects of Embryonic Stem Cell Derived Somatic Cell Therapy of Degenerative Diseases
45. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
46. Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue
47. Pipette-based Method to Study Embryoid Body Formation Derived from Mouse and Human Pluripotent Stem Cells Partially Recapitulating Early Embryonic Development Under Simulated Microgravity Conditions
48. “Watching the Detectives” report of the general assembly of the EU project DETECTIVE Brussels, 24–25 November 2015
49. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells
50. Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.